Table 2 Baseline demographic, clinical and laboratory characteristics of the studied patients
Age (years) | Mean ± SD | 45 ± 16 |
Gender | N (%) | |
Male | 56 (70) | |
Female | 24 (30) | |
Hepatomegaly | N (%) | |
Negative | 43 (53.8) | |
Positive | 37 (46.2) | |
Splenomegaly | N (%) | |
Negative | 29 (36.3) | |
Positive | 51 (63.7) | |
Lymphadenopathy | N (%) | |
Negative | 54 (67.5) | |
Positive | 26 (32.5) | |
Hemoglobin (g/dl) | Mean ± SD | 6.8 ± 1.6 |
TLC (× 109/L) | Mean ± SD | 69 ± 41.7 |
Platelets (× 109/L) | Mean ± SD | 30 ± 17 |
Blast cells (%) | Mean ± SD | 72.2 ± 16.3 |
FAB Classification | N (%) | |
M1 | 11 (13.8) | |
M2 | 44 (55) | |
M4 | 19 (23.8) | |
M5 | 6 (7) | |
Time from diagnosis (days) | Mean ± SD | 94 ± 78 |